G-quadruplex ligand RHPS4 compromises cellular radioresistance by inhibiting the mitochondrial adaptive response induced by ionizing irradiation
NAR Cancer · 2025
DOI: 10.1093/narcan/zcaf033 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Cancer, 2025. Verfasst von Sabine Tricot und 12 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, iRCM/IBFJ, CEA, Genetic Stability, Stem Cells and Radiation, F-92260Fontenay-aux-Roses, France. Hauptthemen laut MEDLINE: G-Quadruplexes, Mitochondria, Radiation Tolerance, Radiation-Sensitizing Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Ligue contre le cancer, CEA, Electricité de France.
Abstract (Originalsprache)
A major challenge in radiotherapy is to enhance tumour cell sensitivity to radiation while minimizing damage to healthy tissues. Enhancing the effectiveness of radiotherapy can be achieved by combining irradiation with small radiosensitizing molecules, which promote cancer cell death and allow for reduced radiation doses, thereby limiting harm to surrounding healthy tissues. Since mitochondria play a key role in tumour cell proliferation, they represent a promising therapeutic target for cancer treatment. In this study, we characterized the impact of irradiation on mitochondrial function in radioresistant cancer cells. Our findings revealed several adaptive responses that may contribute to radioresistance, including increased mitochondrial DNA (mtDNA) content, mitochondrial mass, enhanced activity, and hyperfusion of the mitochondrial network. Notably, the use of mitochondrial-targeted G-quadruplex (G4) ligands, which block mtDNA replication and transcription, disrupted these responses, reducing cancer cell survival in a mtDNA-dependent manner. These results demonstrate that mitochondrial adaptations contribute to radioresistance and highlight mitochondria as a novel target for the radiosensitizing effects of G4 ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Paris-Saclay, iRCM/IBFJ, CEA, Genetic Stability, Stem Cells and Radiation, F-92260Fontenay-aux-Roses, France.
- Université Paris Cité, iRCM/IBFJ, CEA, Genetic Stability, Stem Cells and Radiation, F-92260 Fontenay-aux-Roses, France.
- Université Paris Cité, INSERM, CEA, iRCM/IBFJ, Genetic Stability, Stem Cells and Radiation, F-92260 Fontenay-aux-Roses, France.
- Université Paris-Saclay, INSERM, CEA, iRCM/IBFJ, Genetic Stability, Stem Cells and Radiation, F-92260 Fontenay-aux-Roses, France.
- Platform for Metabolic Analyses, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR 3633, Paris, France.
- University of Angers, MitoLab, Unité MITOVASC, UMR CNRS 6015, INSERM U1083, SFR ICAT, Angers, France.
ORCID-Profile: Guillaume Pinna, J Pablo Radicella, Anna Campalans
Förderung
- The Ligue contre le cancer
- CEA
- Electricité de France
Zitieren
APA
Tricot, S., Siberchicot, C., Bontemps, I., Desmaze, C., Kratassiouk, G., Vandamme, M., Pinna, G., Nemazanyy, I., Radicella, J. P., Lenaers, G., Renaudin, X., Lebeau, J., & Campalans, A. (2025). G-quadruplex ligand RHPS4 compromises cellular radioresistance by inhibiting the mitochondrial adaptive response induced by ionizing irradiation. NAR Cancer. https://doi.org/10.1093/narcan/zcaf033
Vancouver
Tricot S, Siberchicot C, Bontemps I, Desmaze C, Kratassiouk G, Vandamme M, et al. G-quadruplex ligand RHPS4 compromises cellular radioresistance by inhibiting the mitochondrial adaptive response induced by ionizing irradiation. NAR Cancer. 2025. doi:10.1093/narcan/zcaf033
BibTeX
@article{Tricot2025,
author = {Tricot, Sabine and Siberchicot, Capucine and Bontemps, Isaline and Desmaze, Chantal and Kratassiouk, Gueorgui and Vandamme, Marie and Pinna, Guillaume and Nemazanyy, Ivan and Radicella, J Pablo and Lenaers, Guy and Renaudin, Xavier and Lebeau, Jérome and Campalans, Anna},
title = {G-quadruplex ligand RHPS4 compromises cellular radioresistance by inhibiting the mitochondrial adaptive response induced by ionizing irradiation},
journal = {NAR Cancer},
year = {2025},
doi = {10.1093/narcan/zcaf033}
}
EUVIMED